StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)

Analysts at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Down 3.8 %

Shares of AVGR stock opened at $0.55 on Wednesday. The company’s 50 day moving average is $0.75 and its 200 day moving average is $0.97. The firm has a market cap of $1.82 million, a price-to-earnings ratio of -0.05 and a beta of 1.15. Avinger has a 52-week low of $0.39 and a 52-week high of $5.45.

Avinger (NASDAQ:AVGR) last released its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.82) EPS for the quarter, topping the consensus estimate of ($2.03) by $0.21. The firm had revenue of $1.65 million during the quarter, compared to analyst estimates of $1.60 million. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. During the same period in the previous year, the company posted ($2.92) EPS. Analysts anticipate that Avinger will post -4.69 EPS for the current fiscal year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.